×
For best experience we recommend to activate Javascript in your browser.
Recombinant CD70 (Vorsetuzumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
Product Details anti-CD70 (Vorsetuzumab Biosimilar) Antibody
(hide)
Target
See all CD70 (Vorsetuzumab Biosimilar) products
CD70 (Vorsetuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for CD70 (Vorsetuzumab Biosimilar) antibodies
Humanized
Expression System
Mammalian cells
Clonality
All clonalities for CD70 (Vorsetuzumab Biosimilar) antibodies
Chimeric
Conjugate
All conjugates for CD70 (Vorsetuzumab Biosimilar) antibodies
This CD70 (Vorsetuzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Purpose
Research Grade Vorsetuzumab Biosimilar Antibody
Specificity
CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L
Purification
Protein A or G purified from cell culture supernatant.
Purity
>95 % by SDS-PAGE.
Grade
Research Grade
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
2.68 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target Details for CD70 (Vorsetuzumab Biosimilar)
(hide)
Target
CD70 (Vorsetuzumab Biosimilar)
Alternative Name
Vorsetuzumab Biosimilar (CD70 (Vorsetuzumab Biosimilar) Products )
Target Type
Biosimilar
Background
CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L
UniProt
P32970
CAS-No
1165740-62-4
Recently viewed
(hide)